化疗
医学
封锁
危险系数
肿瘤科
内科学
肺癌
癌症
置信区间
受体
作者
Tao Jiang,Qiqi Jin,Jiahao Wang,Fengying Wu,Jian Chen,Gongyan Chen,Yunchao Huang,J. Chen,Ying Cheng,Qiming Wang,Yueyin Pan,Jianying Zhou,Jianhua Shi,Xingxiang Xu,LiZhu Lin,Wei Zhang,Yiping Zhang,Yunpeng Liu,Yong Fang,Jifeng Feng
标识
DOI:10.1158/1078-0432.ccr-23-0604
摘要
These findings suggest that high HED could portend survival benefit in advanced NSCLC treated with first-line PD-1 blockade plus chemotherapy. See related commentary by Dimou, p. 4706.
科研通智能强力驱动
Strongly Powered by AbleSci AI